Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
GORMAN KEVIN CHARLES (CIK 1201096) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy NBIX (14,343 shares), Sell NBIX (7,839 shares), Buy XNCR (10,302 shares), Sell XNCR (7,527 shares), Buy NBIX (205,088 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 14,343 | $0 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 7,839 | $1.2M |
| 2026-07-08 | Xencor Inc (XNCR) | Director | Buy | 10,302 | $0 |
| 2026-06-17 | Xencor Inc (XNCR) | Director | Sell | 7,527 | $92,657 |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 205,088 | $8.9M |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 245,088 | $37.8M |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 5,604 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 3,024 | $375,339 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 5,377 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 2,901 | $360,072 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 63,724 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 34,380 | $4.3M |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 5,142 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 2,845 | $387,091 |
| 2025-08-11 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 106,322 | $3.8M |
| 2025-08-11 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 106,322 | $13.4M |
| 2025-06-16 | Xencor Inc (XNCR) | Director | Buy | 13,686 | $0 |
| 2025-06-16 | Xencor Inc (XNCR) | Director | Sell | 3,173 | $29,255 |
| 2025-05-29 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 9,613 | $1.2M |
Source: SEC Form 4 filings · as of 2026-09-15